News

< Back

Grantees in the News: Kapahi and Killiea research on unrecognized potential drug targets to treat elevated Urinalysis levels in PLOS Genetics

On August 15, PLOS Genetics published research co-authored by AFAR experts Pankaj Kapahi, PhD, and David Killilea, PhD that determined previously unrecognized potential drug targets to treat elevated Urinalysis levels and associated pathologies such as gout or UA kidney stones, with the potential additional benefit of extending human healthspan.

Dr. Kapahi is a 2001 Glenn/AFAR Postdoctoral Fellowship Program for Translational Research on Aging recipient, a 2006 Glenn/AFAR Breakthroughs in Gerontology (BIG) Award recipient, and a 2011 Ellison/AFAR Julie Martin Midcareer Award in Aging Research recipient. He is also a Professor at the Buck Institute for Research on Aging at the University of Southern California.

Dr. Killilea is a 1999 Glenn/AFAR Scholarships for Research in the Biology of Aging recipient, and a 2003 Glenn/AFAR Postdoctoral Fellowship Program for Translational Research on Aging recipient, as well as the Director of the CHORI Elemental Analysis Facility at the Children’s Hospital Oakland Research Institute.

Read the research, “A conserved role of the insulin-like signaling pathway in diet-dependent uric acid pathologies in Drosophila melanogaster,” here.

More Recent News

View All News >
Encouraged by AFAR Amplifying Geroscience Initiative, Congress is directing NIH to tabulate annual spending on geroscience research.
Encouraged by AFAR Amplifying Geroscience Initiative, Congress is directing NIH to tabulate annual spending on geroscience research.
Grantee News: 2022 McKnight Brain Research Foundation Innovator Awards in Cognitive Aging and Memory Loss recipient Tara Tracy, PhD featured as one “next generation of biotech superstars”; publishes research on new strategies for addressing Alzheimer’s and dementia-related memory problems
Grantee News: 2022 McKnight Brain Research Foundation Innovator Awards in Cognitive Aging and Memory Loss recipient Tara Tracy, PhD featured as one “next generation of biotech superstars”; publishes research on new strategies for addressing Alzheimer’s and dementia-related memory problems
AFAR Grantee in the News: New Research by Ömer Yilmaz on the SOX 17 gene and its contributions to Colon cancer detection was published in Nature.
AFAR Grantee in the News: New Research by Ömer Yilmaz on the SOX 17 gene and its contributions to Colon cancer detection was published in Nature.
In Memoriam: Marc Weksler, MD, former AFAR Board President
In Memoriam: Marc Weksler, MD, former AFAR Board President
In Memoriam: Norman Volk, Former AFAR Board Member
In Memoriam: Norman Volk, Former AFAR Board Member
AFAR Grantee in the News: New Research by AFAR Grantee Aditi Gurkar on the molecular index of biological aging published in Aging Cell.
AFAR Grantee in the News: New Research by AFAR Grantee Aditi Gurkar on the molecular index of biological aging published in Aging Cell.
AFAR Grantee in the News: New Research by Dibyadeep Datta on a biomarker that could indicate ensuing Alzheimer's disease published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association
AFAR Grantee in the News: New Research by Dibyadeep Datta on a biomarker that could indicate ensuing Alzheimer's disease published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association
AFAR Grantee in the News: New Research by Mark E. Kleinman on histone dynamics, cellular senescence, and aging in Aging Cell.
AFAR Grantee in the News: New Research by Mark E. Kleinman on histone dynamics, cellular senescence, and aging in Aging Cell.
AFAR News: Gareth W. Shepherd, PhD, and Robert W. Stearns elected to Board of Directors
AFAR News: Gareth W. Shepherd, PhD, and Robert W. Stearns elected to Board of Directors